Since the exogenous GRP78 protein prevented the development of α-syn pathology in our preclinical PD model in rats, we then tested the hypothesis that this effect can lead to the inhibition of the ER stress response and a reduction of apoptosis in the SNpc. The gene discussed is HSPA5; the disease is Parkinson disease.